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Rs 2856717 Effect on the Clinical Manifestations and Poor Outcome of
IgA Nephropathy
Wei Wang, Guisen Li, Yurong Zou, Ping Zhang, Li Wang
Sichuan Provincial People’s Hospital, Chengdu, China
Objectives: To replicate the association of 7 single nucleotide polymorphisms
(SNPs; which were identified as strong association with IgAN in a genome-wide
association study) and investigate whether the 7 SNPs influence the clinical
manifestation and prognostic for IgAN patients, a case-control genetic study
from an independent western Han cohort was conducted.
Methods: Genomic DNA was extracted from 521 patients with IgAN and 535
healthy controls, and TaqMan allelic discrimination assay was used to type
SNP polymorphism. Traditional linear logistic regression analyses were
used to detect 7 SNP associations in dominant, recessive and additive ge-
netic models. Bonferroni correction was used to adjust the P-values for mul-
tiple testing. A total of 459 IgAN patients with integrated clinical data were
investigated the relationship between the genotype and phenotype of IgAN.
315 IgAN patients were followed-up. Then, a retrospective cohort study of
315 IgAN patients was conducted to explore the relationship between geno-
type and the progression of renal disease over a mean period of
44.49 19.94 months.
Results: After Bonferroni correction, no significant SNP association was
observed between IgAN patients and controls (Pc > 0.05). For genotype-
phenotype correlation studies, marginally significant association of rs
2856717 T/C recessive model for the T allele was significantly associated
with eGFR (< 60 ml/min) of IgAN patients (P Z 0.008, Pc Z 0.056,
OR Z 1.527). T allele at position of rs9275596 was significantly associated
with macroscopic hematuria of IgAN patients under the dominant and addi-
tive models of inheritance (P < 0.001, Pc Z 0.007, OR Z 2.983) and
(P < 0.001, PcZ 0.007, ORZ 2.17), respectively. Results from Kaplan-Meier
analysis showed that patients carrying the TT+TC genotype for rs2856717
had reduce renal survival rate than patients carrying the CC genotype
(85.1% vs. 92.7%, P Z 0.046).
Conclusion: Rs 2856717 may influence the clinical manifestations and poor
outcome of IgAN. Further studies are required to definition of the mecha-
nistic effects of genetic variants on clinical traits.Age at biopsy 36.92 (14.97) 36.35 0.821
Sex (male, % in same
category)
31 (34%) 16 (64%) 0.008
Baseline creatinine 152.74 (137.40) 183.53 (178.21) 0.163
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Effect of FK506 on IgA Nephropathy Rats with Mesangial Cell
Proliferation
Lin Ting Wei, Zhe Wang, Li Ning Jia, Jin Han, Xiao Tao Ma, Feng Ming Dong,
Rong Guo Fu
Department of Nephrology, Second Affiliated Hospital, Xi’an Jiaotong
University, Xi’an, Shaanxi Province, China
Objective: To investigate the effect of FK506 on IgAN rats with mesangial cell
proliferation and its relationship with TRPC ion channels and calcineurin.
Methods: IgAN model was established using “BSA + CCl4 + LPS” method, in
which rats were treated with 0.5, 1.0 mg/kg FK506 every day by intragastric
administration for 2 weeks. We measured the hematuria, proteinuria and the
renal function through the laboratory testing. HE staining were conducted to
observe the pathological conditions. RT-PCR and Western Blotting were per-
formed for detecting the rat renal cortical TRPC1, TRPC4/5, TRPC3/6/7 and
calcineurin mRNA and protein expressions.
Results: The levels of hematuria, proteinuria, serum BUN and sCr were elevated
in IgANgroupcomparedwithnormalgroup(P< 0.01),whichcouldbeameliorated
by treating with FK506 (P < 0.05), especially in high dose group (P < 0.01). HE
staining showed that the degree of kidney pathological damage was relatively
milder in high dose group in comparison with IgAN group. The mRNA and protein
levels of TRPC1 (P< 0.01), TRPC6 (P< 0.01, P< 0.05), calcineurin (P< 0.05) and
the protein expression of TRPC4/5 (P < 0.01) in IgAN group were also increased
compared with normal group. FK506 significantly down-regulated TRPC subtypes
and calcineurin mRNA and protein levels in IgAN rats (P < 0.05).
Conclusion: FK506 can significantly reduce the degree of hematuria and pro-
teinuria, improve renal function in IgAN rats, inhibit theproliferation ofmesan-
gial cell. The effect of FK506 on inhibiting mesangial cell proliferation may be
associated with the inhibition of the TRPC ion channels and calcineurin.
Funding: This work was supported by NSFC No. 81300581, 81470968,
81400740, 81100530.http://dx.doi.org/10.1016/j.hkjn.2015.08.116
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Outcome of IgAN With or Without Crescent FormationdA
Restrospective Kidney Survival Analysis
S. K. Chan, H. L. Lo, Y. W. Ho, C. H. Tam, W. C. A. Tang, C. K. D. Lam,
S. H. S. Wong
United Christian Hospital, Hong Kong
Background: Crescentic IgAN (IgA nephropathy) is known to cause rapid
renal function deterioration, similar to other form of IgAN. However
outcome of IgAN with crescent less than 50% glomeruli in Chinese population
is not well understood. Here we included more than 100 patients with
maximal follow up more than 20 years and examined their kidney survival
with or without crescent formation.
Methods:Current patients under the care of our unitwith diagnosis of IgANwere
examination. Patients without full biopsy report were excluded. Baseline char-
acteristics were compared between the two groups. Cox regression analysis was
usedtocompare thekidneysurvival,afteradjusting thebaselinecharacteristics.
End point was defined as either doubling of serum creatinine or starting of RRT,
whichevercameearlier. Survivalwas censored ifpatientdiedbeforeendpointor
kidney survived beyond the end of the study which was 30 June 2015.
Results:191patientswereexaminedand76wereexcluded.Theirbaselinechar-
acteristics are summarized in Table 1. After adjustment was performed, it was
found that presence of crescent itself did not have significant impact on kidney
survival (Table2). Ithas tobenotedthatwhentheonly1casewithmore than50%
crescent formation and poor kidney survival (time from diagnosis to dialysis less
than 2 months) was included to the group with crescent, the result still showed
no significant difference between the two test groups.(umol/L)
